Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Development of recombinant-based mass spectrometric immunoassay with application to resistin expression profiling.

Development of recombinant-based mass spectrometric immunoassay with application to resistin expression profiling. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Development of recombinant-based mass spectrometric immunoassay with application to resistin expression profiling. Abstract Text:

    kemmons a tubbsKemmons A Tubbs,urban a kiernanUrban A Kiernan,eric e niederkoflerEric E Niederkofler,dobrin nedelkovDobrin Nedelkov,allan l bieberAllan L Bieber,randall w nelsonRandall W Nelson,

    This report addresses the need for additional assays for human resistin (hRES) by developing a rational progression of the mass spectrometric immunoassay to incorporate recombinant proteins. The recombinant-based hRES mass spectrometric immunoassay (RES-MSIA) was initially developed for the qualitative analysis of the human resistin homodimer from normal (healthy) plasma samples. The method involved selective extraction and detection of both endogenous and recombinant resistant proteins. RES-MSIA was then applied to the rigorous quantification of resistin. The resistin standard addition curve was constructed from serially diluted concentrations of rhRES using endogenous hRES, inherent in the human plasma, as the internal reference standard (IRS). The roles of endogenous and recombinant resistin were subsequently reversed, using rhRES as the IRS during RES-MSIA quantification. Concurrently, the relative ratio of hRES to rhRES was used as an ancillary technique to rapidly determine the relative concentration of hRES in each of plasma samples. Overall, normal hRES levels determined by RES-MSIA were found to be comparable to those selected and determined by ELISA. With regard to gender, female donor samples were slightly elevated over males. Four single cardiac samples were analyzed and found to have hRES concentrations approximately three times that of the normal. The recombinant-based RES-MSIA is rapid and is amendable to parallel high-throughput robotic processing of resistin related disease cohorts.

    Development of recombinant-based mass spectrometric immunoassay with application to resistin expression profiling. Publishing Authors By Initials

    ka tubbsKA Tubbs,ua kiernanUA Kiernan,ee niederkoflerEE Niederkofler,d nedelkovD Nedelkov,al bieberAL Bieber,rw nelsonRW Nelson,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Development of recombinant-based mass spectrometric immunoassay with application to resistin expression profiling. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: Analytical chemistry

    VOLUME: 78

    Page Numbers: 3271-6

    Journal Abbreviation: Anal. Chem.

    ISSN: 0003-2700

    DAY: 15

    MONTH: May

    YEAR: 2006

    Development of recombinant-based mass spectrometric immunoassay with application to resistin expression profiling. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 370536

    Development of recombinant-based mass spectrometric immunoassay with application to resistin expression profiling. Keywords Mesh Terms:

    KEYWORDS: Spectrometry, Mass, Matrix-Assisted Lase

    MESH TERMS: methods

    Chemical & Substance for Abstract: Development of recombinant-based mass spectrometric immunoassay with application to resistin expression profiling. Information

    Substance Name: Resistin

    Registry Number: 0

    Grant and Affiliation Information for Development of recombinant-based mass spectrometric immunoassay with application to resistin expression profiling.

    AFFILIATION: Intrinsic Bioprobes Inc., 625 South Smith Road, Suite 22, Tempe, AZ 85281, USA. ktubbs@intrinsicbio.com

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NIEHS

    GRANT: N44 ES 35511

    ACRONYM: ES

    MEDLINETA: Anal Chem

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Development of recombinant-based mass spectrometric immunoassay with application to resistin expression profiling Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News